Health In Tech, Inc. (HIT) reported revenue of $33.33M and net income of $1.28M for the fiscal year ended 2025-12-31. This page shows 3 annual periods of income statement, balance sheet and cash flow figures normalized from Health In Tech, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Insurance Agents, Brokers & Service.
Banks, brokers and insurers present a top line that is not comparable with an operating company’s revenue: it is reported net of interest expense, or as premiums earned, depending on the filer. The figures are the filer’s own and are traceable to the filing; the comparison across classes is what does not hold.
Income
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Revenue | $33.33M | $19.49M | $19.15M |
| Cost of revenue | $12.39M | $4.05M | $2.30M |
| Gross profit | $20.94M | $15.44M | $16.85M |
| Operating income | Unavailable | Unavailable | Unavailable |
| Net income | $1.28M | $670.48K | Unavailable |
| Research & development | $1.57M | $2.81M | $2.00M |
| Weighted-average diluted shares | shares 57.74M | shares 53.66M | Unavailable |
| Pretax income | $1.67M | $889.00K | $3.42M |
| Income tax expense | $395.33K | $218.52K | $945.24K |
| Diluted EPS | $0.02 | $0.01 | Unavailable |
| Selling, general & administrative | $17.84M | $11.64M | $11.46M |
| General & administrative | $13.65M | $8.48M | $8.08M |
| Selling & marketing | $4.19M | $3.16M | $3.38M |
Balance
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash & equivalents | $7.67M | $7.85M | $2.42M |
| Total assets | $23.09M | $15.77M | $11.50M |
| Current assets | $16.16M | $10.78M | $6.86M |
| Total liabilities | $5.98M | $2.60M | $5.41M |
| Current liabilities | $5.16M | $2.13M | $4.78M |
| Total equity incl. NCI | $17.11M | $13.17M | $6.09M |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable |
| Inventory | Unavailable | Unavailable | Unavailable |
| Accounts receivable | $756.29K | $1.65M | $2.24M |
| Goodwill | Unavailable | Unavailable | Unavailable |
| Long-term debt | Unavailable | Unavailable | Unavailable |
| Accounts payable | Unavailable | Unavailable | Unavailable |
Cash flow
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating cash flow | $3.13M | $2.18M | $1.53M |
| Capital expenditures | Unavailable | Unavailable | Unavailable |
| Investing cash flow | -$3.13M | -$836.76K | -$1.94M |
| Financing cash flow | -$187.39K | $4.09M | $1.34M |
| Net change in cash | Unavailable | Unavailable | Unavailable |
| Stock-based compensation | $1.57M | $468.49K | Unavailable |
| Common dividends paid | Unavailable | Unavailable | Unavailable |
| Common share repurchases | Unavailable | Unavailable | Unavailable |
| Depreciation & amortization | $900.58K | $541.14K | $339.30K |
Derived
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Free cash flow | Unavailable | Unavailable | Unavailable |
| Gross margin | 62.8% | 79.2% | 88.0% |
| Operating margin | Unavailable | Unavailable | Unavailable |
| FCF margin | Unavailable | Unavailable | Unavailable |
| SBC / revenue | 4.7% | 2.4% | Unavailable |
| Current ratio | 3.13x | 5.06x | 1.43x |
| Revenue YoY growth | 71.0% | 1.8% | Unavailable |
| Net margin | 3.8% | 3.4% | Unavailable |
| R&D / revenue | 4.7% | 14.4% | 10.5% |
| CapEx / revenue | Unavailable | Unavailable | Unavailable |
| Long-term debt / equity | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 23.6% | 24.6% | 27.6% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open HIT in the interactive workspace to inspect any figure back to its filing.
Source filings
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.